Gene Editing Market, Global Outlook and Forecast 2024-2030

1 Introduction to Research & Analysis Reports
1.1 Gene Editing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Editing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Editing Overall Market Size
2.1 Global Gene Editing Market Size: 2024 VS 2030
2.2 Global Gene Editing Market Size, Prospects & Forecasts: 2024-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Gene Editing Players in Global Market
3.2 Global Companies Gene Editing Product & Technology
4 Gene Editing Companies Profiles
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Company Summary
4.1.2 Thermo Fisher Scientific Business Overview
4.1.3 Thermo Fisher Scientific Gene Editing Product Offerings & Technology
4.1.4 Thermo Fisher Scientific Gene Editing R&D, and Plans
4.2 Merck
4.2.1 Merck Company Summary
4.2.2 Merck Business Overview
4.2.3 Merck Gene Editing Product Offerings & Technology
4.2.4 Merck Gene Editing R&D, and Plans
4.3 Horizo??n Discovery
4.3.1 Horizo??n Discovery Company Summary
4.3.2 Horizo??n Discovery Business Overview
4.3.3 Horizo??n Discovery Gene Editing Product Offerings & Technology
4.3.4 Horizo??n Discovery Gene Editing R&D, and Plans
4.4 Sangamo BioSciences
4.4.1 Sangamo BioSciences Company Summary
4.4.2 Sangamo BioSciences Business Overview
4.4.3 Sangamo BioSciences Gene Editing Product Offerings & Technology
4.4.4 Sangamo BioSciences Gene Editing R&D, and Plans
4.5 Integrated DNA Technologies
4.5.1 Integrated DNA Technologies Company Summary
4.5.2 Integrated DNA Technologies Business Overview
4.5.3 Integrated DNA Technologies Gene Editing Product Offerings & Technology
4.5.4 Integrated DNA Technologies Gene Editing R&D, and Plans
4.6 Lonza
4.6.1 Lonza Company Summary
4.6.2 Lonza Business Overview
4.6.3 Lonza Gene Editing Product Offerings & Technology
4.6.4 Lonza Gene Editing R&D, and Plans
4.7 New England Biolabs
4.7.1 New England Biolabs Company Summary
4.7.2 New England Biolabs Business Overview
4.7.3 New England Biolabs Gene Editing Product Offerings & Technology
4.7.4 New England Biolabs Gene Editing R&D, and Plans
4.8 OriGene Technologies
4.8.1 OriGene Technologies Company Summary
4.8.2 OriGene Technologies Business Overview
4.8.3 OriGene Technologies Gene Editing Product Offerings & Technology
4.8.4 OriGene Technologies Gene Editing R&D, and Plans
4.9 Transposagen Biopharmaceuticals
4.9.1 Transposagen Biopharmaceuticals Company Summary
4.9.2 Transposagen Biopharmaceuticals Business Overview
4.9.3 Transposagen Biopharmaceuticals Gene Editing Product Offerings & Technology
4.9.4 Transposagen Biopharmaceuticals Gene Editing R&D, and Plans
4.10 Editas Medicine
4.10.1 Editas Medicine Company Summary
4.10.2 Editas Medicine Business Overview
4.10.3 Editas Medicine Gene Editing Product Offerings & Technology
4.10.4 Editas Medicine Gene Editing R&D, and Plans
4.11 CRISPR Therapeutics
4.11.1 CRISPR Therapeutics Company Summary
4.11.2 CRISPR Therapeutics Business Overview
4.11.3 CRISPR Therapeutics Gene Editing Product Offerings & Technology
4.11.4 CRISPR Therapeutics Gene Editing R&D, and Plans
4.12 RGen Solutions
4.12.1 RGen Solutions Company Summary
4.12.2 RGen Solutions Business Overview
4.12.3 RGen Solutions Gene Editing Product Offerings & Technology
4.12.4 RGen Solutions Gene Editing R&D, and Plans
4.13 Sigma-Aldrich
4.13.1 Sigma-Aldrich Company Summary
4.13.2 Sigma-Aldrich Business Overview
4.13.3 Sigma-Aldrich Gene Editing Product Offerings & Technology
4.13.4 Sigma-Aldrich Gene Editing R&D, and Plans
4.14 GeneCopoeia
4.14.1 GeneCopoeia Company Summary
4.14.2 GeneCopoeia Business Overview
4.14.3 GeneCopoeia Gene Editing Product Offerings & Technology
4.14.4 GeneCopoeia Gene Editing R&D, and Plans
4.15 Genscript Biotech
4.15.1 Genscript Biotech Company Summary
4.15.2 Genscript Biotech Business Overview
4.15.3 Genscript Biotech Gene Editing Product Offerings & Technology
4.15.4 Genscript Biotech Gene Editing R&D, and Plans
5 Sights by Region
5.1 By Region - Global Gene Editing Market Size, 2025 & 2030
5.2 By Region - Global Gene Editing Revenue, (2025-2030)
5.3 United States
5.3.1 Key Players of Gene Editing in United States
5.3.2 United States Gene Editing Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Gene Editing in Europe
5.4.2 Europe Gene Editing Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Gene Editing in China
5.5.2 China Gene Editing Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Gene Editing Market Size Markets, 2025 & 2030
6.2 Zinc finger nucleases (ZFNs)
6.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
6.4 CRISPR-Cas system
7 Sights by Application
7.1 By Application - Global Gene Editing Market Size, 2025 & 2030
7.2 Biotechnology & Pharmaceutical Companies
7.3 Academic & Government Research Institutes
7.4 Contract Research Organizations
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer